G.M. AKHMEDOVA¹^,², D.Kh. SHAKIROVA³

¹Kazan State Medical Academy, 36 Butlerov St., Kazan, Russian Federation, 420012

²Republican Clinical and Diagnostic Center for demyelinating diseases of the MH of RT, 13 Vatutin St., Kazan, Russian Federation, 420021

³Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

Akhmedova G.M. — Cand. Med. Sc., Associate Professor of the Department of Neurology and Manual Therapy, tel. (843) 278-97-28, e-mail: guzel29@mail.ru

Shakirova D.Kh. — Doctor of Pharmacy, Professor of the Department of Administration and Economics of Pharmacy, tel. (843) 521-39-53, e-mail: dhabilevna@mail.ru

The review and analysis of literature data on modern tendencies of treatment of multiple sclerosis and specific of its drug therapy are presented in this article. The morbidity rate of multiple sclerosis and volumes of financial expenses on medicines for treatment of multiple sclerosis were analyzed.

Key words: multiple sclerosis, incidence, pharmacoeconomics, the Republic of Tatarstan.